1 |
Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022. [PMID: 35931818 DOI: 10.1038/s41577-022-00762-9] [Reference Citation Analysis]
|
2 |
Stakišaitis D, Kapočius L, Valančiūtė A, Balnytė I, Tamošuitis T, Vaitkevičius A, Sužiedėlis K, Urbonienė D, Tatarūnas V, Kilimaitė E, Gečys D, Lesauskaitė V. SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review. Biomedicines 2022;10:962. [DOI: 10.3390/biomedicines10050962] [Reference Citation Analysis]
|
3 |
Lim EHT, van Amstel RBE, de Boer VV, van Vught LA, de Bruin S, Brouwer MC, Vlaar APJ, van de Beek D. Complement activation in COVID-19 and targeted therapeutic options: A scoping review. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100995] [Reference Citation Analysis]
|
4 |
Conway EM, Pryzdial ELG. Complement contributions to COVID-19. Curr Opin Hematol 2022. [PMID: 35852851 DOI: 10.1097/MOH.0000000000000724] [Reference Citation Analysis]
|